As our understanding of cancer has evolved, so too has the promise of personalized oncology — treatment tailored to each ...

SPOT-MAS is a blood test developed by Gene Solutions to detect multiple features of circulating tumor DNA (ctDNA) released from cancer cells, indicating if someone may have cancer. Previously, ...

Dr. Alan Tan spoke with CURE® about what patients with kidney cancer and providers who treat it may be able to learn from ...

Cancer Check Labs is live in 44 states and has the ability to test for any solid tumor with a 40 ml blood draw.

RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced ...

On World Cancer Day, it is essential to spread awareness about how emerging technologies are transforming cancer care and the ...

During a Case-Based Roundtable event, Laura Huppert, MD, discussed data and considerations around using T-DXd in breast ...

Patients with colon cancer who still have cancer cells in their blood after surgery may improve their survival odds with ...

编辑丨王多鱼排版丨水成文抗 PD-1 联合仑伐替尼（lenvatinib，一种多靶点受体酪氨酸激酶抑制剂）治疗在多种肿瘤中均显示出临床疗效，但潜在的免疫学机制尚不清楚。2025 年 1 月 30 ...

A panel discussion during the JPMorgan conference earlier this month examined where oncology drug development is headed, driven in part by advances in diagnostic testing.

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

One wealth manager who pays more than $20,000 a year for membership to a longevity clinic in London was told he had some calcification in the arteries in his neck, as well as an elevated genetic risk ...